Synonyms:iohexol, 66108-95-0, Omnipaque, Nycodenz, Exypaque, Iohexolum, Omnipaque 240, Omnipaque 70, Omnipaque 140, Omnipaque 180, Omnipaque 210, Omnipaque 300, Omnipaque 350, WIN 39424, Oraltag, WIN-39424, CHEBI:31709, N,N'-Bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide, DTXSID6023157, 5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide, N1,N3-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide, 4419T9MX03, NSC-759636, NCGC00166000-01, 5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamide, 1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-, DTXCID803157, Histodenz, Iohexolum [INN-Latin], 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide, 5-[N-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamide, N1,N3-bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide, SMR000857075, EINECS 266-164-2, BRN 2406632, UNII-4419T9MX03, Omnipaque (TN), 1,3-benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-, n,n'-bis(2,3-dihydroxypropyl)-5-[n-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide, Prestwick_802, CAS-66108-95-0, Iohexol [USAN:USP:INN:BAN:JAN], IOHEXOL [VANDF], IOHEXOL [USAN], IOHEXOL [INN], IOHEXOL [JAN], IOHEXOL [MI], IOHEXOL [MART.], Prestwick0_000512, Prestwick1_000512, Prestwick2_000512, Prestwick3_000512, IOHEXOL [USP-RS], IOHEXOL [WHO-DD], IOHEXOL [WHO-IP], Nycodenz;Omnipaque;Exypaque, EC 266-164-2, Iohexol, analytical standard, SCHEMBL26501, BSPBio_000463, MLS001332585, MLS001332586, MLS002153854, Iohexol (JP17/USP/INN), IOHEXOL [EP IMPURITY], IOHEXOL [ORANGE BOOK], SPBio_002384, IOHEXOL [EP MONOGRAPH], BPBio1_000511, IOHEXOL [USP MONOGRAPH], CHEMBL1200455, BCBcMAP01_000051, IOHEXOLUM [WHO-IP LATIN], HMS1569H05, HMS2096H05, HMS2235D07, HMS3369O04, HMS3713H05, ALBB-028959, AMY21804, BCP31800, HY-B0594, Tox21_112286, BDBM50247977, MFCD00077732, s4531, AKOS015895399, Tox21_112286_1, AC-1934, CCG-220512, DB01362, NSC 759636, SMP1_000152, NCGC00166000-02, NCGC00166000-04, AS-12699, FT-0627276, I0903, D01817, D91214, Histodenz(TM), nonionic density gradient medium, A835339, EN300-19628570, Q410683, SR-01000838892, SR-01000838892-2, Iohexol, European Pharmacopoeia (EP) Reference Standard, Iohexol, United States Pharmacopeia (USP) Reference Standard, 5-(N-dhp-acetamido)-2,4,6-triiodo-N,N'-B is-dhp-isophthalami, Iohexol, Pharmaceutical Secondary Standard; Certified Reference Material, Iohexol for peak identification, European Pharmacopoeia (EP) Reference Standard, 1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo, 1-N,3-N-bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide, N1,N3-bis[2,3-bis(oxidanyl)propyl]-5-[2,3-bis(oxidanyl)propyl-ethanoyl-amino]-2,4,6-tris(iodanyl)benzene-1,3-dicarboxamide
Pubchem:PUBCHEM:3730
Id:01750aed-ce42-5efb-be5d-2e8b8a0edd4f
Description:nan
